L. Cannella, M. Breccia, G. Loglisci, V. Federico, M. Santopietro, and G. Alimena, “Safety and efficacy of nilotinib in chronic phase chronic myeloid leukemia in a patient with Wolf-Parkinson-White disease and hematological resistance after suboptimal response to imatinib at six months”, AO, vol. 49, no. 3, pp. 399–400, Jan. 2010.